EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Cuprizone Mouse Model: A Comparative Study of Cuprizone Formulations from Different Manufacturers

Malena Beecken, Louise Baumann, Elise Vankriekelsvenne, Katerina Manzhula, Theresa Greiner iD, Leo Heinig iD, Steffen Schauerte, Markus Kipp iD, Sarah Joost iD

International Journal of Molecular Sciences · 23.06.2023 · 24 (13) · 10564

DOI: 10.3390/ijms241310564 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.06.2023. Verfasst von Malena Beecken und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Anatomy, Rostock University Medical Center, 18057 Rostock, Germany. Hauptthemen laut MEDLINE: Cuprizone, Demyelinating Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rostock University Medical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Cuprizone mouse model is widely used in studies on de- and remyelination. In the hands of different experimenters, the Cuprizone concentrations that lead to comparable levels of demyelination differ considerably. The reasons for this variability are unknown. In this study, we tested whether different Cuprizone formulations from different vendors and manufacturers influenced Cuprizone-induced histopathological hallmarks. We intoxicated male C57BL/6 mice with six Cuprizone powders that differed in their manufacturer, vendor, and purity. After five weeks, we analyzed the body weight changes over the course of the experiment, as well as the demyelination, astrogliosis, microgliosis and axonal damage by histological LFB-PAS staining and immunohistochemical labelling of PLP, IBA1, GFAP and APP. All Cuprizone formulations induced demyelination, astrogliosis, microgliosis, axonal damage and a moderate drop in body weight at the beginning of the intoxication period. In a cumulative evaluation of all analyses, two Cuprizone formulations performed weaker than the other formulations. In conclusion, all tested formulations did work, but the choice of Cuprizone formulation may have been responsible for the considerable variability in the experimental outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CuprizoneDemyelinating DiseasesMaleAnimalsMiceGliosisMice, Inbred C57BLBody WeightDisease Models, AnimalMyelin Sheath

Stichwörter der Autor:innen

Cuprizone mouse modelastrogliosisdemyelinationmicrogliosis

Substanzen

Cuprizone

Autor:innen und Institutionen

  • Institute of Anatomy, Rostock University Medical Center, 18057 Rostock, Germany.
  • Institute of Organic Chemistry, RWTH Aachen University, 52074 Aachen, Germany.

ORCID-Profile: Theresa Greiner, Leo Heinig, Markus Kipp, Sarah Joost

Förderung

  • Rostock University Medical Center

Zitieren

APA

Beecken, M., Baumann, L., Vankriekelsvenne, E., Manzhula, K., Greiner, T., Heinig, L., Schauerte, S., Kipp, M., & Joost, S. (2023). The Cuprizone Mouse Model: A Comparative Study of Cuprizone Formulations from Different Manufacturers. International Journal of Molecular Sciences, 24(13), 10564. https://doi.org/10.3390/ijms241310564

Vancouver

Beecken M, Baumann L, Vankriekelsvenne E, Manzhula K, Greiner T, Heinig L, et al. The Cuprizone Mouse Model: A Comparative Study of Cuprizone Formulations from Different Manufacturers. International Journal of Molecular Sciences. 2023;24(13):10564. doi:10.3390/ijms241310564

BibTeX
@article{Beecken2023,
  author = {Beecken, Malena and Baumann, Louise and Vankriekelsvenne, Elise and Manzhula, Katerina and Greiner, Theresa and Heinig, Leo and Schauerte, Steffen and Kipp, Markus and Joost, Sarah},
  title = {The Cuprizone Mouse Model: A Comparative Study of Cuprizone Formulations from Different Manufacturers},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {13},
  pages = {10564},
  doi = {10.3390/ijms241310564}
}
Kostenlos starten →